Preclinical CRO Market Size, Share & Trends Report

Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End Use (Biopharmaceutical Companies, Government & Academic Institutes), By Region And Segment Forecasts, 2024 - 2030

Report ID: GVR-2-68038-035-4
Number of Pages: 275
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

Preclinical CRO Service Outlook (Revenue, USD Billion, 2018 - 2030)
- Bioanalysis and DMPK studies
  - In vitro ADME
  - In-vivo PK
- Toxicology Testing
  - GLP
  - Non-GLP
- Compound Management
  - Process R&D
  - Custom Synthesis
  - Others
- Chemistry
  - Medicinal Chemistry
  - Computation Chemistry
- Safety Pharmacology
- Others
Preclinical CRO Model Type Outlook (Revenue, USD Billion, 2018 - 2030)
- Patient Derived Organoid (PDO) Model
- Patient derived xenograft model
Preclinical CRO End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
Preclinical CRO Market: Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - North America Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
    - Bioanalysis and DMPK studies
      - In vitro ADME
      - In-vivo PK
    - Toxicology Testing
      - GLP
      - Non-GLP
    - Compound Management
      - Process R&D
      - Custom Synthesis
      - Others
    - Chemistry
      - Medicinal Chemistry
      - Computation Chemistry
    - Safety Pharmacology
    - Others
  - North America Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
    - Patient Derived Organoid (PDO) Model
    - Patient derived xenograft model
  - North America Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
    - Biopharmaceutical Companies
    - Government and Academic Institutes
    - Medical Device Companies
  - U.S.
    - U.S. Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - U.S. Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - U.S. Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Canada
    - Canada Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Canada Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Canada Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
- Europe
  - Europe Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
    - Bioanalysis and DMPK studies
      - In vitro ADME
      - In-vivo PK
    - Toxicology Testing
      - GLP
      - Non-GLP
    - Compound Management
      - Process R&D
      - Custom Synthesis
      - Others
    - Chemistry
      - Medicinal Chemistry
      - Computation Chemistry
    - Safety Pharmacology
    - Others
  - Europe Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
    - Patient Derived Organoid (PDO) Model
    - Patient derived xenograft model
  - Europe Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
    - Biopharmaceutical Companies
    - Government and Academic Institutes
    - Medical Device Companies
  - U.K.
    - U.K. Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - U.K. Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - U.K. Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Germany
    - Germany Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Germany Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Germany Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - France
    - France Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - France Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - France Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Italy
    - Italy Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Italy Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Italy Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Spain
    - Spain Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Spaine Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Spain Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Sweden
    - Sweden Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Sweden Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Sweden Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Norway
    - Norway Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Norway Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Norway Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Denmark
    - Denmark Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Denmark Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Denmark Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
- Asia Pacific
  - Asia Pacific Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
    - Bioanalysis and DMPK studies
      - In vitro ADME
      - In-vivo PK
    - Toxicology Testing
      - GLP
      - Non-GLP
    - Compound Management
      - Process R&D
      - Custom Synthesis
      - Others
    - Chemistry
      - Medicinal Chemistry
      - Computation Chemistry
    - Safety Pharmacology
    - Others
  - Asia Pacifice Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
    - Patient Derived Organoid (PDO) Model
    - Patient derived xenograft model
  - Asia Pacific Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
    - Biopharmaceutical Companies
    - Government and Academic Institutes
    - Medical Device Companies
  - Japan
    - Japan Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Japan Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Japan Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - China
    - China Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - China Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - China Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - India
    - India Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - India Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - India Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - South Korea
    - South Korea Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - South Korea Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - South Korea Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Australia
    - Australia Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Australia Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Australia Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Thailand
    - Thailand Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Thailand Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Thailand Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
- Latin America
  - Latin America Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
    - Bioanalysis and DMPK studies
      - In vitro ADME
      - In-vivo PK
    - Toxicology Testing
      - GLP
      - Non-GLP
    - Compound Management
      - Process R&D
      - Custom Synthesis
      - Others
    - Chemistry
      - Medicinal Chemistry
      - Computation Chemistry
    - Safety Pharmacology
    - Others
  - Latin America Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
    - Patient Derived Organoid (PDO) Model
    - Patient derived xenograft model
  - Latin America Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
    - Biopharmaceutical Companies
    - Government and Academic Institutes
    - Medical Device Companies
  - Brazil
    - Brazil Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Brazil Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Brazil Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Mexico
    - Mexico Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Mexico Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Mexico Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Argentina
    - Argentina Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Argentina Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Argentina Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
- Middle East & Africa
  - Middle East & Africa Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
    - Bioanalysis and DMPK studies
      - In vitro ADME
      - In-vivo PK
    - Toxicology Testing
      - GLP
      - Non-GLP
    - Compound Management
      - Process R&D
      - Custom Synthesis
      - Others
    - Chemistry
      - Medicinal Chemistry
      - Computation Chemistry
    - Safety Pharmacology
    - Others
  - Middle East & Africa Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
    - Patient Derived Organoid (PDO) Model
    - Patient derived xenograft model
  - Middle East & Africa Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
    - Biopharmaceutical Companies
    - Government and Academic Institutes
    - Medical Device Companies
  - South Africa
    - South Africa Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - South Africa Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - South Africa Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Saudi Arabia
    - Saudi Arabia Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Saudi Arabia Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Saudi Arabia Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - UAE
    - UAE Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - UAE Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - UAE Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies
  - Kuwait
    - Kuwait Preclinical CRO Market, By Service, 2018 - 2030 (USD Billion)
      - Bioanalysis and DMPK studies
        
        In vitro ADME
        
        In-vivo PK
      - Toxicology Testing
        
        GLP
        
        Non-GLP
      - Compound Management
        
        Process R&D
        
        Custom Synthesis
        
        Others
      - Chemistry
        
        Medicinal Chemistry
        
        Computation Chemistry
      - Safety Pharmacology
      - Others
    - Kuwait Preclinical CRO Market, By Model Type, 2018 - 2030 (USD Billion)
      - Patient Derived Organoid (PDO) Model
      - Patient derived xenograft model
    - Kuwait Preclinical CRO Market, By End-use, 2018 - 2030 (USD Billion)
      - Biopharmaceutical Companies
      - Government and Academic Institutes
      - Medical Device Companies

Preclinical CRO Market Dynamics

Driver: Growing R&D Offshoring

The geographic distribution of R&D activities is slowly shifting from developed nations to emerging countries. Rising R&D expenditure coupled with an increase in failure rates of R&D activities has caused biopharmaceutical companies to prefer regions such as Central and Eastern Europe, Asia Pacific, and Latin America & Middle East for ensuring cost saving and quick patient recruitment. Outsourcing of preclinical trials to regions such as Asia Pacific also provides greater economic benefits to biopharmaceutical companies. Governments of countries such as the UK, Singapore, and China are allocating funds to promote biomedical research in this region. For instance, in October 2022, the UK government declared that more than USD 1,018 million (GBP 800 million) of funding will be provided to the National Institute for Health and Care Research (NIHR) to support specialized research facilities that bring together scientists to foster an environment conducive to the advancement of experimental medicine and patient safety research.

Driver: Rising Outsourcing Trend

Demand for CROs is increasing due to rising R&D expenditure and the growing focus of pharmaceutical companies on cost containment. Biopharmaceutical companies choose to outsource their early development R&D functions to CROs to reduce product development time and costs. This trend is expected to continue over the forecast period due to the increasing capabilities of CROs to conduct complex research, which enables life sciences companies to reduce R&D expenditure & focus on their core activities. In addition, collaborations of biopharmaceutical companies with CROs are expected to positively impact the global preclinical CRO market. For instance, in August 2021, Eurofins Scientific partnered with Fusion Antibodies; this partnership is aimed at providing the best antibodies for a wide range of diseases. The partnership agreement is for 2 years and involves the usage of advanced technology.

Restraint: Monitoring Issues and Lack of Standardization

The growth of the preclinical CRO market is restrained due to issues in the management and monitoring of trials and the inability to exert complete control over trials. Sometimes, CROs are unable to deliver efficient results as expected by life sciences companies, as they try to maximize profits by cutting costs. This may result in several challenges such as trial failures and compliance issues. Furthermore, there is a lack of standardization as not all CROs comply with international regulatory requirements such as Good Laboratory Practice (GLP) standards, which may lead to several quality issues. Therefore, biopharmaceutical and medical device companies generally outsource only lower-end functions of preclinical trials to CROs, whereas high-end tests such as genotoxicity analysis are generally performed in-house. However, improvement in quality standards adopted by CROs is expected to overcome the standardization challenge as outsourced vendors are currently trying to comply with the international standards set by regulatory authorities such as the U.S. FDA and the European Medicines Agency (EMA). Such actions by CROs are expected to improve the standardization of preclinical activities in the long term.

What Does This Report Include?

This section will provide insights into the contents included in this preclinical CRO market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Preclinical CRO market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Preclinical CRO market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.